John Hendrickson faces a daunting challenge: One year into his tenure as chief executive of drugmaker Perrigo, he must convince investors he has a handle on the company’s wobbly business.
WSJ.com: US Business, Wall Street Journal: Business
Mon, 04/24/2017 - 4:00am
John Hendrickson faces a daunting challenge: One year into his tenure as chief executive of drugmaker Perrigo, he must convince investors he has a handle on the company’s wobbly business.